Profitability
Weight: 25%
F
5
- 5yr Avg ROIC -12.7%
- Operating Margin Trend -1.23 pp/yr
TXG
10x Genomics, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
2
- 5yr Avg ROE -18.7%
- 5yr Share-Count CAGR 4.3%
Growth Quality
Weight: 25%
A
89
- 5yr Revenue CAGR 16.6%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 20%
F
0
- 5yr FCF Margin -9.6%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 10%
A+
100
- Net Debt / EBITDA -93.55x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 18.26
Stability
Weight: 5%
C+
61
- Negative-Revenue Years (5) 1/5
- Piotroski F-Score 4
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.5 of 5 gurus held; 2 new buys; 1 added; 2 trimmed.
- Holders
- 5 +2
- Avg Δ position
- +58.1%
- New buys
- 2
- Full exits
- 0
- Druckenmiller new
- Wood new
- Cooperman increased +240%